SAVA Cassava Pharma: Bozor qiymatining balans qiymatiga nisbati
Cassava Sciences, Inc. (SAVA) narxlarining ushbu grafigi qat'iy tartibga soluvchi nazorat va ma'lumotlar aniqligi bo'yicha bahslar fonidagi tebranishlarni namoyish etadi, bunda xavf 1.41 darajasida turibdi. Cassava Sciences, Inc. (SAVA) simufilamning yakuniy sinovlari orqali bozorda ustunlikka erishishga intilmoqda. Shu bilan birga, kompaniya Alzheimer kasalligi sabablarini yo'q qilish uchun fundamental neyrobiologiyadan foydalangan holda, demensiyani davolashning kompleks yondashuvini ishlab chiqmoqda.
Cassava Sciences Inc (SAVA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Cassava Sciences, Inc.|SAVA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Cassava|SAVA - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Cassava|SAVA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Cassava Sciences|Tezkor likvidlik cassavasciences.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Cassava Sciences, Inc. - SAVA
Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlariga solishtirib, kompaniya uchun ortiqcha to'lov qilinganini aniqlaydi. Birga solishtirganda yuqori qiymatlar kelajakdagi o'sish yoki nomoddiy aktivlar uchun premiumni anglatadi. Bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book ratio) dagi o'zgarishlarni tahlil qilish orqali investor spekulyativ shovqinni fundamental qiymatdan ajratadi. Cassava Sciences, Inc. (SAVA) uchun ushbu farq simufilamning FDA tomonidan tasdiqlanishiga oid bozor kutuvlarini aks ettiradi.
Asosiy raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|neurocrine.com (NBIX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com (TRVI)|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|Bozor kapitallashuvining balans qiymatiga nisbati Anavex (AVXL)|Bozor qiymatining balans qiymatiga nisbati CeriBell Corp CBLL|Balans qiymatiga nisbatan bozor kapitallashuvi Prothena (PRTA)|ALEC - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi annexonbio.com ANNX|OMER: Bozor kapitallashuvining balans qiymatiga nisbati|Neurogene Inc (NGNE) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati ACIU|Bozor qiymatining balans qiymatiga nisbati VYGR|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|Bozor kapitallashuvining balans qiymatiga nisbati scilexholding.com (SCLX)|Tevogen Bio - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ACOG|CGTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Inhibikase Pharma IKT|ASRT: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Coya Therapeutics|VTGN (VistaGen Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Ovid Rx (OVID) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|CRVO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Alterity Therapeutics Limited ATHE|CLNN: Kapitallashuvning balans qiymatiga nisbati|PepGen Corp - Bozor kapitallashuvining balans qiymatiga nisbati|jupiterneurosciences.com (JUNS) - Kapitallashuvning sof aktivlarga nisbati|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Annovis Bio Corporation (ANVS)|Bozor qiymatining balans qiymatiga nisbati Grace Therapeutics Inc|fireflyneuro.com (AIFF) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati KLTO (Klotho Neurosciences Inc)|NRSN (neurosense-tx.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati RVPH (Reviva Pharmaceuticals Holdings)|Balans qiymatiga nisbatan bozor kapitallashuvi MetaVia Inc. (MTVA)|NRXS - Bozor qiymatining balans qiymatiga nisbati|HSDT (Helius Medical) - Kapitallashuvning balans qiymatiga nisbati|PASG: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Neuphoria Therapeutics|Kapitallashuvning sof aktivlarga nisbati NERV|Athira Pharma Corp (ATHA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Addex Therapeutics (ADXN)|Balans qiymatiga nisbatan bozor kapitallashuvi alzamend.com|Bozor kapitallashuvining balans qiymatiga nisbati CYCN (Cyclerion Therapeutics, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Protagenic Therapeutics Inc. PTIX|KTTA: Kapitallashuvning sof aktivlarga nisbati|CRGT: Bozor qiymatining balans qiymatiga nisbati|ATXI: Bozor kapitallashuvining balans qiymatiga nisbati|brainstorm-cell.com (BCLI) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics|Kapitallashuvning balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corp)|Bozor kapitallashuvining balans qiymatiga nisbati ELYM|ITCI - Bozor qiymatining balans qiymatiga koeffitsiyenti|Longboard Pharmaceuticals - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati marinuspharma.com MRNS|NKGN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc (SNPX)|TRVN (Trevena, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Vigil Neuro (VIGL)|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Bozor kapitallashuvining balans qiymatiga nisbati Cerevel Therapeutics Inc (CERE)